EHA HIGHLIGHTS 2024 – LEUKEMIA ROUNDTABLE DISCUSSION: PHALLCON TRIAL
OR
Chair
Dr. Jorge Cortes
Panelists
Dr. Julie Bergeron
Dr. Aniket Bankar
This program has been made possible through unrestricted support from Astellas.
Studies/trials discussed:
- PhALLCON trial
- In-depth analysis of responders in the phase 3 PhALLCON trial of ponatinib vs imatinib in newly diagnosed Ph+ ALL.
